Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
Molecular Cancer Therapeutics|March 18, 2004
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activityJames Turkson, Joon S Kim, Shumin Zhang, et al.
The Journal of Biological Chemistry|February 13, 2002
Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cellsXianwu Li, Li Liu, Joan C Tupper, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseJuliana Ruiz-Caro, Aravind Basavapathruni, Joseph T Kim, et al.
Cancer Letters|December 27, 2005
Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cellsAikaterini Anagnostopoulou, Adina Vultur, Rozanne Arulanandam, et al.
RSC Medicinal Chemistry|September 12, 2022
Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leadsBrandon Drennen, Christopher C Goodis, Nathan Bowen, et al.
Biochemical and Biophysical Research Communications|January 25, 2017
CG13250, a novel bromodomain inhibitor, suppresses proliferation of multiple myeloma cells in an orthotopic mouse modelNatsuki Imayoshi, Makoto Yoshioka, Jay Chauhan, et al.
Nucleic Acid Therapeutics|May 27, 2026
Unraveling the Stereochemical Complexity of Phosphorothioate-Modified Oligonucleotides Using Analytical TechnologiesAkanksha Manghrani, Maharshi C Patel, Frank Delaglio, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseVinay V Thakur, Joseph T Kim, Andrew D Hamilton, et al.
Pageof 26